Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial

This publication has 11 references indexed in Scilit:

• Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2016
• Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
  The Lancet Infectious Diseases, 2016
• Tenofovir alafenamide for HIV infection: is less more?
  The Lancet, 2015
• Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
  The Lancet, 2015
• Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
• Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era
  Patient Preference and Adherence, 2012
• Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
  The Journal of Infectious Diseases, 2011
• Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study
  Clinical Infectious Diseases, 2010
• Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
  Clinical Infectious Diseases, 2010
• Tenofovir-Associated Fanconi Syndrome: Review of the FDA Adverse Event Reporting System
  AIDS Patient Care and STDs, 2008